Cargando…
Pharmacological inhibition of epidermal growth factor receptor attenuates intracranial aneurysm formation by modulating the phenotype of vascular smooth muscle cells
AIM: To study the effect of pharmacological inhibition of epidermal growth factor receptor (EGFR) on intracranial aneurysm (IA) initiation. METHODS: Human IA samples were analyzed for the expression of p‐EGFR and alpha smooth muscle actin (α‐SMA) by immunofluorescence (IF). Rat models of IA were est...
Autores principales: | Luo, Yin, Tang, Haishuang, Zhang, Zhaolong, Zhao, Rui, Wang, Chuanchuan, Hou, Wenguang, Huang, Qinghai, Liu, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673708/ https://www.ncbi.nlm.nih.gov/pubmed/34729926 http://dx.doi.org/10.1111/cns.13735 |
Ejemplares similares
-
Hsa_circ_0031608: A Potential Modulator of VSMC Phenotype in the Rupture of Intracranial Aneurysms
por: Wang, Chuanchuan, et al.
Publicado: (2022) -
Underlying mechanism of hemodynamics and intracranial aneurysm
por: Tang, Haishuang, et al.
Publicado: (2021) -
Nrf-2 signaling inhibits intracranial aneurysm formation and progression by modulating vascular smooth muscle cell phenotype and function
por: Shi, Yuan, et al.
Publicado: (2019) -
Lymphocytes influence intracranial aneurysm formation and rupture: role of extracellular matrix remodeling and phenotypic modulation of vascular smooth muscle cells
por: Sawyer, David M., et al.
Publicado: (2016) -
Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway
por: Li, Sichen, et al.
Publicado: (2020)